Study on BMP-2 on Inducing OPG-/-BMSCs Differentiate into Osteogenesis in vitro

doi:10.3969/j.issn.1674-5817.2012.03.003

Abstract

Abstract: Objective To investigate the effect of bone morphogenetic protein-2(BMP-2) on inducing OPG^-/- BMSCs differentiate into the osteogenesis in vitro, and to evaluate the effect of BMP-2 Bioactive Peptides inducing to osteoplast and dose dependent. Methods Got the femur of mice, separated the BMSCs and cultured in vitro. Followed by passaged the BMSCs to P1 using the conditioned medium, and then the BMSCs were added in the BMP-2 consistency of 0.3 μg、0.2 μg、0.1 μg、0.05 μg、0 μg separately cultured with 15% FBS culture medium, marked A, B, C, D, and E group in order. The 3^rd, 5^th, 7^th day after cell culture, the expression of alkaline phosphatase was detected by PNPP method, and calcium content was detected by Calcium kit. The expression of tatrate-resistant acid phosphatase form 5 b in the cell supernatant detected by ELISA, To investigate the effect of different concentration bone morphogenetic protein-2 (BMP-2) on inducing OPG^-/- BMSCs differentiate into the osteogenesis in vitro. Results The activity of alkaline phosphatase and calcium content showed that group A and group B both increase higher than the other group (P<0.05). However no significant differences were detected between the group A and B (P>0.05). TRACP5b displayed, TRACP5b expression in group A, B and C is lower than the other groups in the 3^rd, 5^th, 7^th day (P<0.05), no significant differences were detected between the group A and B (P>0.05). Conclusions The BMP-2 had significant effect on inducing OPG^-/- BMSCs differentiate into the osteogenesis in vitro. The effect dependent on the different concentration of bone morphogenetic protein-2(BMP-2), the optimal concentration is 0.2 μg/ml.

Key words: Bone morphogenetic protein-2(BMP-2), OPG^-/- mouse, Bone marrow derived stroma cell

CLC Number:

Q95-33

ZHANG Chun,WEI Qin,WANG Xue-mei,et al. Study on BMP-2 on Inducing OPG^-/-BMSCs Differentiate into Osteogenesis in vitro[J]. Laboratory Animal and Comparative Medicine, 2012, 32(3): 186-190. DOI: 10.3969/j.issn.1674-5817.2012.03.003.

References

[1] Ebara S, Nadayama K.Mechanism for the action of bone morphogenetic proteins and regulation of their activity[J]. Spine, 2002, 27(16 Suppl 1):10-15.
[2] Chen D, Zhao M, Mundy GR.Bone morphogenetic proteins[J]. Growth Factors, 2004, 22(4):233-241.
[3] 段智霞, 郑启新, 郭晓东, 等. BMP-2活性多肽体外定向诱导大鼠BMSCs向成骨方向分化的实验研究[J]. 中国矫形外科杂志, 2007, 15(21):1647-1650.
[4] 杨小荣, 方煌, 罗永湘. 重组人骨形成蛋白2 与骨诱导剂对大鼠骨髓间充质干细胞增殖分化的影响[J]. 中国修复重建外科杂志, 2007, 21(2):140-144.
[5] 岳冰, 陈燕飞, 汤亭亭, 等. 骨形成蛋白2 基因修饰的老年大鼠骨髓间充质干细胞成骨分化能力的研究[J]. 中国修复重建外科杂志, 2006, 20(1):53-57.
[6] Mizuno A, Amizuka N, Irie K, et al.Severe osteoporosis in mice lacking osteocastogenesis inhibitory factor/osteoprotegerin[J]. Biochem and Biophys Res Commun, 1998, 247(3):610-615.
[7] Wozney JM, Seeh erman HJ. Protein -based tissue engineering in bone and cartilage repair[ J]. Curr Opin Biotechnol, 2004, 15(5):392-398.
[8] Saito N, Takaoka K.New synthetic biodegradabl epolymers as BMP carriers for bone tissue engineering[J]. Biomaterials, 2003, 24(13):2287-2293.
[9] Chadderdon RC, Shimer AL, Gilbertson LG, et al.Advances in gene therapy for intervertebral disc degeneration[J]. Spine J, 2004, 4(6 s uppl):341-347.
[10] Geiger M, Li RH, Friess W.Collagen sponges for bone regeneration with rhBMP-2[J]. Adv Drug Deliv Rev, 2003, 55(12):1613-1629.
[11] Tsumaki N, Yoshikawa H.The role of bone morphogenetic proteins in endochondral bone formation[J]. Cytokine Growth Factor Rev, 2005, 16(3):279-285.
[12] Kugimiya F, Kawaguchi H, Chung UI.BMP and bone formation[ J].Clin Calcium, 2004, 14(1):173-179.
[13] Kirsch T, Nickel J, Sebald W.BMP-2 antagonists emerge from alterati on sin the low -aff inity binding epitope for receptor BMPRⅡ. EM BO J, 2000, 19(13):3314-3324.
[14] Kirsch T, Sebald W, Dreyer MK.Crystal structure of the BMP-2-BRIA ectodomain complex[J]. Nat St ruct Biol, 2000, 7(6):492-496.
[15] 杨小荣, 方煌, 罗永湘. 重组人骨形成蛋白2 与骨诱导剂对大鼠骨髓间充质干细胞增殖分化的影响[J]. 中国修复重建外科杂志, 2007, 21(2):140-144.
[16] 郁卫东, 秦书俭. 骨形态发生蛋白-2 在骨形成过程中的作用机制[ J].中国临床解剖学杂志, 2000, 18(1):82-83.
[17] 赵广跃, 胡蕴玉, 刘建, 等. rhBMP2 诱导效应的体内和体外观察[J]. 解放军医学杂志, 2005, 30(12):1118.
[18] 张超, 胡蕴玉, 徐建强, 等. 骨相关生长因子对兔骨髓基质干细胞生长及分化的量效作用[J]. 中国修复重建外科杂志, 2005, 19(11):906-909.
[19] Alatalo SL, Halleen JM, Hentunen TA, et al.Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium.[ J]. J Clin Chem, 2000, 46(11):1751-1754.
[20] Halleen JM, Alatalo SL, Suominen H, et al.Tartrate-resistant acid phosphatase 5b :a novel serum marker of bone resorption[J]. J Bone Miner Res, 2000, 15(7):1337-1345.
[21] Chen B, Lin H, Wan g J, et al. Homogeneous osteogenesis and bone regenerat ion by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2[J]. Biomaterials, 2007, 28(6):1027-1035.
[22] 赵广跃, 胡蕴玉, 刘建, 等. rhBMP 不同动物异位诱导成骨及其小鼠体内诱导成骨的剂量依赖性[J]. 陕西医学杂志, 2006, 35(3):260-263.
[23] 张为西, 陈松林, 姚晓黎, 等. BMP-2和FGF-2对小鼠骨髓间充质干细胞向成骨细胞分化的影响[J]. 细胞与分子免疫学杂志, 2008, 24(11):1062-1065.
[24] 钱栋, 马鹏, 李阳, 等. 骨形成蛋白-2结合纤维连接蛋白体外诱导骨髓间充质干细胞分化为成骨细胞的观察[J]. 江苏大学学报(医学版), 2009, 19(2):117-120.

Study on BMP-2 on Inducing OPG^-/-BMSCs Differentiate into Osteogenesis in vitro

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	JIAO Qingzhen, WU Guihua, TANG Wen, FAN Fan, FENG Kai, YANG Chunxiang, QIAO Jian, DENG Sufang. Dynamic Monitoring and Analysis of Ammonia Concentration in Laboratory Animal Facilities Under Suspension of Heating Ventilation and Air Conditioning System [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 490-495.
[2]	LIU Wentao, LUO Yanhong, LONG Yongxia, LUO Qihui, CHEN Zhengli, LIU Lida. Common Environmental Problems and Testing Experiences in Laboratory Animal Facilities in Sichuan Province [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 483-489.
[3]	ZHAO Xin, WANG Chenxi, SHI Wenqing, LOU Yuefen. Advances in the Application of Zebrafish in the Research of Inflammatory Bowel Disease Mechanisms and Drug Development [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 422-431.
[4]	GONG Leilei, WANG Xiaoxia, FENG Xuewei, LI Xinlei, ZHAO Han, ZHANG Xueyan, FENG Xin. A Mouse Model and Mechanism Study of Premature Ovarian Insufficiency Induced by Different Concentrations of Cyclophosphamide [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 403-410.
[5]	LIN Zhenhua, CHU Xiangyu, WEI Zhenxi, DONG Chuanjun, ZHAO Zenglin, SUN Xiaoxia, LI Qingyu, ZHANG Qi. Evaluation of the Safety and Efficacy of Bone Cement in Experimental Pigs Using Vertebroplasty [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 466-472.
[6]	JIANG Juan, SONG Ning, LIAN Wenbo, SHAO Congcong, GU Wenwen, SHI Yan. Comparison of Histopathological and Molecular Pathological Phenotypes in Mouse Models of Intrauterine Adhesions Induced by Two Concentrations of Ethanol Perfusion [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 393-402.
[7]	LIU Yueqin, XUE Weiguo, WANG Shuyou, SHEN Yaohua, JIA Shuyong, WANG Guangjun, SONG Xiaojing. Observation of Digestive Tract Tissue Morphology in Mice Using Probe-Based Confocal Laser Endomicroscopy [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 457-465.
[8]	ZHENG Qingyong, YANG Donghua, MA Zhichao, ZHOU Ziyu, LU Yang, WANG Jingyu, XING Lina, KANG Yingying, DU Li, ZHAO Chunxiang, DI Baoshan, TIAN Jinhui. Recommendations for Standardized Reporting of Systematic Reviews and Meta-Analysis of Animal Experiments [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 496-507.
[9]	WANG Tingjun, LUO Hao, CHEN Qi. Discussion on AI-Based Digital Upgrade and Application Practice of Laboratory Animal Centers [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 473-482.
[10]	WANG Jiaoxiang, ZHANG Lu, CHEN Shuhan, JIAO Deling, ZHAO Heng, WEI Taiyun, GUO Jianxiong, XU Kaixiang, WEI Hongjiang. Construction and Functional Validation of GTKO/hCD55 Gene-Edited Xenotransplant Donor Pigs [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 379-392.
[11]	QIN Chao, LI Shuangxing, ZHAO Tingting, JIANG Chenchen, ZHAO Jing, YANG Yanwei, LIN Zhi, WANG Sanlong, WEN Hairuo. Study on the 90-day Feeding Experimental Background Data of SD Rats for Drug Safety Evaluation [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 439-448.
[12]	LIU Kun, LAN Qing, YI Bing, XIE Xiaojie. Key Challenges and Mitigation Strategies for Animal Pregnancy in Non-clinical Reproductive Toxicity Testing of Drugs [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 449-456.
[13]	. [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 508-514.
[14]	CHEN Ziyi, SUN Hongyan, KANG Pinfang, WU Wenjuan. Research Advances in Animal Experimental Models of Pulmonary Hypertension [J]. Laboratory Animal and Comparative Medicine, 2025, (): 1-12.
[15]	XU Yingtao, WANG Mengmeng, LIN Ping, CHI Haitao, WANG Yi, BAI Ying. Exosomes Improve Ischemic Stroke by Regulation of Ferroptosis Through the NRF2/SLC7A11/GPX4 Pathway in Mice [J]. Laboratory Animal and Comparative Medicine, 2025, (): 1-11.